References

  1. Prince JS. Adenocarcinome. In: Duhamel DR, Harrell JH. Atlas clinique des maladies des voies aériennes: Endoscopie, radiologie, histolopathologie. Elsevier Masson. Lille 2007; pp. 38-4. Google Scholar

  2. Bryant A, Cerfolio RJ. Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers that develop non-small cell lung cancer. Chest. 2007; 132(1): 185-9. PubMed | Google Scholar

  3. Subramanian J, Govindan R. Lung cancer in never smokers: a review. J Clin Oncol. 2007; 25 (5) :561-70. PubMed | Google Scholar

  4. Tefferi A, Thiele J, Vardiman JW. The 2008 Word HealthOrganization classification system for myeloproliferativeneoplasms: order out of chaos. Cancer. 2009; 115:3842-7. PubMed | Google Scholar

  5. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F et al. 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013; 65:1-11. PubMed | Google Scholar

  6. Seo JB, Im JB, Goo JM, Chung MJ, Kim MY. Atypical pulmonary metastases: spectrum of radiologic findings. Radiographics. 2001; 21(2) :403-17. PubMed | Google Scholar

  7. Vazquez M, Carter D, Brambilla E, Gazdar A, Noguchi M, Travis WD et al. Solitary and multiple resected adenocarcinomas after CT screening for lung cancer: Histopathologic feactures and their prognostic implications. Lung Cancer. 2009; 64(2):148-54. PubMed | Google Scholar

  8. Shiner RJ, Rosenman J, Katz I, Reichart N, Hershko E, Yellin A. Bronchoscopicevaluation of peripherallungtumours. Thorax. 1988; 43(11): 887-9. PubMed | Google Scholar

  9. Weir BA, Woo MS, Getz G, Perner S, Ding L, Beroukhim R et al. Characterizing the cancer genome in lung adenocarcinoma. Nature. 2007; 450(7171): 893-8. PubMed | Google Scholar

  10. Lu TP, Hsiao CK, Lai LC, Tsai MH, Hsu CP, Lee JM, Chuang EY. Identification of regulatory SNP sassociated with genetic modifications in lung adenocarcinoma. BMC Res Notes. 2015; 8:92. PubMed | Google Scholar

  11. Zhang Y, Tang H, Li J, Li M. An active treatment of lungadenocarcinoma cancer withbrainmetastases: icotinib. OncoTargetsTher. 2015; 8: 1351-4. PubMed | Google Scholar